DM
ABMD

Deerfield Management’s Abiomed Inc ABMD Stock Holding History

Deerfield Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-376,000
Closed -$54.6M – 110
2020
Q1 		$54.6M Buy
+376,000
New +$62.4M 1.73% 15
2019
Q4 		– Sell
-27,600
Closed -$4.91M – 102
2019
Q3 		$4.91M Buy
+27,600
New +$5.97M 0.2% 73
2016
Q2 		– Sell
-49,797
Closed -$4.72M – 119
2016
Q1 		$4.72M Buy
+49,797
New +$4.2M 0.2% 73
2014
Q4 		– Sell
-435,934
Closed -$10.8M – 136
2014
Q3 		$10.8M Buy
+435,934
New +$11M 0.39% 68

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Deerfield Management's ABMD Position: Q2 2020 in Review

Deerfield Management sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 376,000 shares — an estimated $54.6M sold.

Deerfield Management first reported a position in ABMD in Q3 2014 and held it in 4 quarters. The position peaked at $54.6M in Q1 2020. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Deerfield Management reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Deerfield Management sold 376,000 Abiomed Inc shares in Q2 2020, an estimated $54.6M.
  • Deerfield Management first reported a position in Abiomed Inc in Q3 2014 and held it in 4 quarters.
  • Deerfield Management's Abiomed Inc position peaked at $54.6M in Q1 2020.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Deerfield Management's 13F filing for Q2 2020, filed 14 Aug 2020.